• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Sarepta Therapeutics (NQ: SRPT )

    154.20 -2.55 (-1.63%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,327,133
    Open 156.46
    Bid (Size) 154.25 (2)
    Ask (Size) 157.52 (10)
    Prev. Close 156.75
    Today's Range 153.65 - 156.70
    52wk Range 55.25 - 173.25
    Shares Outstanding 93,148,652
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Expert Outlook: Sarepta Therapeutics Through The Eyes Of 25 Analysts
    Via Benzinga
    Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    From Sarepta Therapeutics, Inc.
    Via Business Wire

    Performance

    YTD
    +60.27%
    +60.27%
    1 Month
    +24.12%
    +24.12%
    3 Month
    +20.09%
    +20.09%
    6 Month
    +60.27%
    +60.27%
    1 Year
    +35.87%
    +35.87%

    More News

    Read More
    Looking At Sarepta Therapeutics's Recent Unusual Options Activity
    Via Benzinga
    Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.
    Via The Motley Fool
    Here's How Much You Would Have Made Owning Sarepta Therapeutics Stock In The Last 10 Years
    Via Benzinga
    Sarepta Therapeutics Scores 90-Plus RS Rating On Muscular Dystrophy Approval
    Via Investor's Business Daily
    Micron To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Monday
    Via Benzinga
    DraftKings And Dell Were Among The 10 Biggest Large Cap Stock Gainers Last Week (June 16-June 22): Are These In Your Portfolio?
    Via Benzinga
    Google Parent Alphabet At All-Time High, In Stock Spotlight: See New Names On IBD 50, Stock Spotlight And More
    Via Investor's Business Daily
    Growth Stocks Leave Value Stocks In The Dust: 4 Reasons For Biggest Monthly Lead In Over A Year
    Via Benzinga
    Nasdaq Moves Lower; FactSet Research Posts Upbeat Earnings
    Via Benzinga
    Why Kaival Brands Innovations Shares Are Trading Lower By 47%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty
    Via Benzinga
    Stocks Stall As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
    Via Benzinga
    Sarepta's Expanded FDA Approval For Elevidys Potentially Shaping Future FDA Reviews, Analyst Says
    Via Benzinga
    Exposures Product Safety
    Gold Down 1%; CarMax Shares Gain After Q1 Earnings
    Via Benzinga
    Sarepta Therapeutics Stock Soars on FDA Approval
    Via MarketBeat
    Exposures Product Safety
    Why Is Ascent Solar (ASTI) Stock Up 11% Today?
    Via InvestorPlace
    Why Is 36Kr (KRKR) Stock Up 17% Today?
    Via InvestorPlace
    Asana, Clover Health Investments, Hertz Global And Other Big Stocks Moving Higher On Friday
    Via Benzinga
    Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance
    Via Investor's Business Daily
    Topics Artificial Intelligence Stocks
    Exposures Artificial Intelligence US Equities
    Pre-Market Movers - June 21, 2024
    Via Talk Markets
    Sarepta Therapeutics (SRPT) Stock Surges 30% on Giant FDA Boost
    Via InvestorPlace
    Exposures Product Safety
    Apple To Rally Over 14%? Here Are 10 Top Analyst Forecasts For Friday
    Via Benzinga
    Why Sarepta Therapeutics Shares Are Trading Higher By Around 35%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.